Official EU label nameGlossary entry 14153
KETOCONAZOLE
This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.
Global evidence snapshot
The resolved identity has matching regulatory evidence in 8 of 13 indexed market datasets: 8 country records and 0 EU Annex records. Every result and evidence gap is listed below.
Markets checked
13
Markets with evidence
8
Evidence gaps
5
Resolved identifiers
10
A missing local match is not permission, approval or proof of safety. It means no strong identity match was resolved in that indexed dataset.
Resolved substance identity
CAS:65277-42-187-10-567-96-9536-33-467-45-8443-48-167-20-960-56-01404-88-2
EC:265-667-4
Ingredient index records:
KETOCONAZOLE
Cosmetic functions: NOT REPORTED
Ketoconazole is the heterocyclic compound that conforms to the formula
Inventory restriction note: II/1528
8 matched or reported names
KETOCONAZOLEKetoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanoneKetoconazole (1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethenone)Ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-抗感染类药物，包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物（磺胺和其氨基的一 个或多个氢原子被取代的衍生物）及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide （Tribromsalan （INN） ）（CAS No. 87-10-5）, Antibiotics, Dihydrotachysterol （INN） （CAS No. 67-96-9）, Ethionamide （INN） （CAS No. 536-33-4）, Furazolidone （INN） （CAS No. 67-45-8）, Ketoconazole （CAS No. 65277-42-1）, Metronidazole （CAS No. 443-48-1）, Nitrofurantoin （INN） （CAS No. 67-20-9）, Sulphonamides （sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups） and their salts, Thiamazole （INN） （CAS No. 60-56-0）, Thyrothricine （CAS No. 1404-88-2）케토코나졸Cetoconazol (KETOCONAZOLE)Ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4- yl]methoxy]phenyl] piperazin-1-yl]ethenone (CAS No. 65277-42-1)
Regulatory evidence in all 13 markets
Open each matched record for its scope, concentration, conditions, warnings and official source version.
Swipe or scroll horizontally to see dataset coverage and next actions.
| Market | Result | Records | Dataset | Meaning / next action |
|---|---|---|---|---|
| European Union EU | No local match | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | Prohibited | 1Open record 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | Review every linked record and exact conditions. |
| Canada CA | No local match | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Prohibited | 1Open record 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | Review every linked record and exact conditions. |
| ASEAN ASEAN | Prohibited | 1Open record 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Review every linked record and exact conditions. |
| China CN | Prohibited | 1Open record 1 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | Review every linked record and exact conditions. |
| Japan JP | No local match | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Prohibited | 1Open record 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Review every linked record and exact conditions. |
| United States US | No local match | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | No local match | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Prohibited | 1Open record 1 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | Review every linked record and exact conditions. |
| India IN | Prohibited | 1Open record 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | Review every linked record and exact conditions. |
| Saudi Arabia SA | Prohibited | 1Open record 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | Review every linked record and exact conditions. |
No market rows match this filter.
Matching market records and conditions
New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026South Korea
MFDS Notice 2026-19, effective 18 March 2026Brazil
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026Chemical identity and properties
CAS 1404-88-2PubChem CID 452550
Tyrothricin
- IUPAC name
- 3-[(3R,6S,9S,12S,15S,17S,20S,22R,25S,28S)-20-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,22,25-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,18,21,24,27-nonaoxo-12-propan-2-yl-1,4,7,10,13,16,19,23,26-nonazabicyclo[26.3.0]hentriacontan-17-yl]propanoic acid
- Molecular formula
- C65H85N11O13
- Molecular weight
- 1228.4 g/mol
- Exact mass
- 1227.63283181 Da
- XLogP3
- 1.9
- Topological polar surface area
- 380.0 Ų
- Hydrogen-bond donors
- 12
- Hydrogen-bond acceptors
- 15
- Covalent units
- 1
- Defined stereocentres
- 10
Also known as
BactratycinColtirotDermotricineHydrotricineMartricinTirotricinaTyrothricineSolutricine
16 more reported names
TyrothricinumTyrodermTyrosurDubos crude crystalsTyri 10NSC-757363RefChem:192767D06AX08R02AB02S01AA05215-771-0PharothricettenBiothricinGinotricinaRinotricinaTriciderm
External database identifiers
- ChEMBL:CHEMBL577736
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 443-48-1PubChem CID 4173
Metronidazole
- IUPAC name
- 2-(2-methyl-5-nitroimidazol-1-yl)ethanol
- Molecular formula
- C6H9N3O3
- Molecular weight
- 171.15 g/mol
- Exact mass
- 171.06439116 Da
- XLogP3
- 0.0
- Topological polar surface area
- 83.9 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 4
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
MetronidazolGineflavir2-Methyl-5-nitroimidazole-1-ethanolDeflamonOrvagilTrichazolMetroGelSanatrichom
16 more reported names
AnagiardilDanizolMeronidalMetronidazMexibolTrichocideTricocetTrivazolVagilenVagimidArilinClontKlionBayer 5360MetronidazoloAcromona
External database identifiers
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 536-33-4PubChem CID 2761171
Ethionamide
Ethionamide is a thiocarboxamide that is pyridine-4-carbothioamide substituted by an ethyl group at position 2. A prodrug that undergoes metabolic activation by conversion to the corresponding S-oxide. It has a role as an antitubercular agent, an antilipemic drug, a leprostatic drug, a fatty acid synthesis inhibitor and a prodrug. It is a member of pyridines and a thiocarboxamide. — ChEBI
- IUPAC name
- 2-ethylpyridine-4-carbothioamide
- Molecular formula
- C8H10N2S
- Molecular weight
- 166.25 g/mol
- Exact mass
- 166.05646950 Da
- XLogP3
- 1.1
- Topological polar surface area
- 71.0 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
TrecatorEthioniamideAmidazineEthinamideEthyonomideEtionamidEtioniamid2-Ethylthioisonicotinamide
16 more reported names
NizotinEthylisothiamideTeberusTrecator-SCAmidazinBayer 5312IridocinIridozinSertinonThianideTrescatylEtionid4-Pyridinecarbothioamide, 2-ethyl-EtionizinEtionizineEthimide
External database identifiers
- ChEBI:CHEBI:4885
- ChEMBL:CHEMBL1441
- EPA DTXSID:DTXSID0020577
- PubMed:33814510
- PubMed:32808185
- PubMed:26708503
- PubMed:26062974
- PubMed:25051504
- PubMed:23112434
- PubMed:23107633
- PubMed:23106273
- PubMed:23020577
- PubMed:23019444
- PubMed:22952439
- PubMed:22904807
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 60-56-0PubChem CID 1349907
Methimazole
Methimazole is a member of the class of imidazoles that it imidazole-2-thione in which a methyl group replaces the hydrogen which is attached to a nitrogen. It has a role as an antithyroid drug. — ChEBI
- IUPAC name
- 3-methyl-1H-imidazole-2-thione
- Molecular formula
- C4H6N2S
- Molecular weight
- 114.17 g/mol
- Exact mass
- 114.02516937 Da
- XLogP3
- -0.3
- Topological polar surface area
- 47.4 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 1
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
thiamazoleTapazole1-Methyl-1H-imidazole-2-thiolMethimazol1-Methylimidazole-2-thiolMercazolylThiamazolMercazole
16 more reported names
ThymidazolThymidazoleFavistanMercaptazoleMetothyrineMetazoloMetothyrinStrumazolThycapzolDanantizolFrentiroxMerkazolilMetotirinThacapzolBasolanMercasolyl
External database identifiers
- ChEBI:CHEBI:50673
- ChEMBL:CHEMBL1515
- EPA DTXSID:DTXSID4020820
- PubMed:41580965
- PubMed:38685447
- PubMed:34788025
- PubMed:34757178
- PubMed:33814510
- PubMed:32808185
- PubMed:32020584
- PubMed:31697382
- PubMed:31629072
- PubMed:31066087
- PubMed:30814441
- PubMed:30320502
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 65277-42-1PubChem CID 47576
Ketoconazole
(2S,4R)-ketoconazole is a cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine which dioxolane moiety has (2S,4R)-configuration. It is an enantiomer of a (2R,4S)-ketoconazole. — ChEBI
- IUPAC name
- 1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
- Molecular formula
- C26H28Cl2N4O4
- Molecular weight
- 531.4 g/mol
- Exact mass
- 530.1487608 Da
- XLogP3
- 4.3
- Topological polar surface area
- 69.1 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 6
- Covalent units
- 1
- Defined stereocentres
- 2
Also known as
NizoralPanfungolKetodermFungarestFungoralKetoisdinKetozoleExtina
16 more reported names
Orifungal MNizoral a-DKetoconazolXolegelKetoconazolumPiperazine, 1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, cis-R 41400R9400W927ICHEBI:47519Piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-, cis-R-41400DandrazolDandridKetopineNizorelle(+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine
External database identifiers
- ChEBI:CHEBI:47518
- ChEMBL:CHEMBL295698
- EPA DTXSID:DTXSID60161949
- PubMed:40976440
- PubMed:38795739
- PubMed:38734219
- PubMed:37788138
- PubMed:37077353
- PubMed:36893891
- PubMed:36653537
- PubMed:36621641
- PubMed:36374910
- PubMed:36332690
- PubMed:35478211
- PubMed:35358606
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 67-20-9PubChem CID 6604200
Nitrofurantoin
Nitrofurantoin is an imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA. It has a role as an antiinfective agent, an antibacterial drug and a hepatotoxic agent. It is an imidazolidine-2,4-dione, an organonitrogen heterocyclic antibiotic, an organooxygen heterocyclic antibiotic and a nitrofuran antibiotic. It is functionally related to a semicarbazide. — ChEBI
- IUPAC name
- 1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione
- Molecular formula
- C8H6N4O5
- Molecular weight
- 238.16 g/mol
- Exact mass
- 238.03381930 Da
- XLogP3
- -0.5
- Topological polar surface area
- 121.0 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 6
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
FuradantinMacrodantin5-NitrofurantoinFuradantoinFuradoninFuradontinNifurantinFuralan
16 more reported names
MacrobidOrafuranParfuranUrantoinIturanNitrofurantoinaNitrofurantoineBerkfurinChemiofuranFurachelFuradoineFuradonineFuratoinFurobactinaNovofuranTrantoin
External database identifiers
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 67-45-8PubChem CID 5323714
Furazolidone
Furazolidone is a member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera. It has a role as an antiinfective agent, an antibacterial drug, an EC 1.4.3.4 (monoamine oxidase) inhibitor and an antitrichomonal drug. It is a member of oxazolidines and a nitrofuran antibiotic. — ChEBI
- IUPAC name
- 3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
- Molecular formula
- C8H7N3O5
- Molecular weight
- 225.16 g/mol
- Exact mass
- 225.03857033 Da
- XLogP3
- -0.1
- Topological polar surface area
- 101.0 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 6
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
FuroxoneNitrofurazolidoneFurazolidineNitrofuroxonDiafuronFurazolFuridonNeftin
16 more reported names
FuraxoneFurazolidonFuroxaneNifulidoneFurazonFuroxonGiarlamNitrofurazolidonumFurozolidineNifurazolidoneTikofuranTrichofuronTricofuronCoryziumFuraxonFuroxal
External database identifiers
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 67-96-9PubChem CID 5311071
Dihydrotachysterol
Dihydrotachysterol is a hydroxy seco-steroid that is 9,10-secoergosta-5,7,22-triene substituted by a hydroxy group at position 3. A synthetic analogue of vitamin D that acts a bone density conservation agent. It has a role as a bone density conservation agent. It is a vitamin D, a seco-ergostane and a hydroxy seco-steroid. — ChEBI
- IUPAC name
- trans-(1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
- Molecular formula
- C28H46O
- Molecular weight
- 398.7 g/mol
- Exact mass
- 398.354866087 Da
- XLogP3
- 7.7
- Topological polar surface area
- 20.2 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 1
- Covalent units
- 1
- Defined stereocentres
- 7
Also known as
DichystrolumAntitanilHytakerolTachystinDihidrotaquisterolDihydrotachysterol2DihydralDygratyl
16 more reported names
ParterolTachyrolAnti-tetany substance 10DihydrotachysterolumDHT2DiidrotachisteroloDihydrotachysterol 2AT 10Tachysterol, dihydro-Tachysterol2, dihydro-A.T. 10R5LM3H112RTachysterol dihydro derivativeCHEBI:45919,10-Secoergosta-5,7,22-trien-3beta-ol(1S,3E,4S)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylcyclohexan-1-ol
External database identifiers
- ChEBI:CHEBI:4591
- ChEMBL:CHEMBL2356023
- EPA DTXSID:DTXSID5022938
- PubMed:15585789
- PubMed:10515239
- PubMed:6262039
- PubMed:4365509
- PubMed:3320562
- PubMed:198519
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 87-10-5PubChem CID 14868
3,4',5-Tribromosalicylanilide
- IUPAC name
- 3,5-dibromo-N-(4-bromophenyl)-2-hydroxybenzamide
- Molecular formula
- C13H8Br3NO2
- Molecular weight
- 449.92 g/mol
- Exact mass
- 448.80847 Da
- XLogP3
- 5.0
- Topological polar surface area
- 49.3 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
TribromsalanTemasept IVTrisanilTuasol 100ET-394NSC-205266MCE3VTF0OSalicylanilide, 3,4',5-tribromo-
16 more reported names
BENZAMIDE, 3,5-DIBROMO-N-(4-BROMOPHENYL)-2-HYDROXY-WR-34912CHEBI:127105DiapheneTemaceptRefChem:899088201-723-63,5,4'-TribromosalicylanilideAgramedTRIBROMOSALICYLANILIDETemasept IITrisanylTempasept IISherstat TBSVancide TBSTribromsalanum
External database identifiers
- ChEBI:CHEBI:127105
- ChEMBL:CHEMBL24944
- EPA DTXSID:DTXSID4026181
- PubMed:33352258
- PubMed:21826158
- PubMed:20922970
- PubMed:20067776
- PubMed:19668425
- PubMed:18479921
- PubMed:17228788
- PubMed:12755728
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Additional authoritative substance research
These source-specific lookups can add hazard, toxicology, identity and assessment context. A link is a research route, not a claim that the source contains an exact record.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Research this identityFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Research this identityILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Research this identityJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Research this identityNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Research this identityOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Research this identityUS EPA CompTox CTX APIs
DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Research this identityContinue the compliance check
1. Confirm identity
Match the supplier specification, CAS/EC identifiers and composition to this official label name. Similar wording is not proof of chemical equivalence.
2. Review restrictions
Check every exact Annex record shown above, plus CMR, nanomaterial, SCCS and later-amendment requirements that may apply.
3. Verify the formula
Evaluate concentration, product type, purity, warnings, claims and each target market before making a compliance decision.
Official source and scope
Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.
Open official Decision